Beck O, Seidl C, Lehrnbecher T, Kreyenberg H, Schwabe D, Klingebiel T, Seifried E, Bader P, Koehl U
Paediatric Haematology and Oncology, J.W. Goethe University Frankfurt/Main, Germany.
Eur J Haematol. 2006 Mar;76(3):237-44. doi: 10.1111/j.1600-0609.2005.00588.x.
Chimerism analysis has become a routine diagnostic procedure after haematopoietic allogeneic stem cell transplantation for early detection of relapse of disease or graft failure. Whereas some centres developed individual in-house short tandem repeat (STR) systems, others prefer commercial multiplex PCR systems. However, little is known about inter-assay variation, which could have a significant impact on treatment decision. We therefore compared two commercial multiplex PCR kits with our in-house STR system using different sample sources, such as peripheral blood (PB), bone marrow (BM) and specific leukocyte subsets.
Fifty samples of eighteen paediatric patients were analysed. For neither material, PB, BM and leukocyte subtypes, a significant difference between the STR systems tested was observed. Chimerism analyses of each single STR primer, which is component of both the in-house and the commercial STR system, did not reveal significant differences.
Our analysis demonstrates that similar results can be obtained with both assays, even when using various sample sources. Further evaluation of different test systems will help to increase interlaboratory standardisation of chimerism analyses for early clinical intervention.
嵌合体分析已成为异基因造血干细胞移植后的常规诊断程序,用于疾病复发或移植物失败的早期检测。一些中心开发了各自的内部短串联重复序列(STR)系统,而其他中心则倾向于使用商业多重聚合酶链反应(PCR)系统。然而,关于不同检测方法间的差异知之甚少,而这可能会对治疗决策产生重大影响。因此,我们使用不同的样本来源,如外周血(PB)、骨髓(BM)和特定白细胞亚群,将两种商业多重PCR试剂盒与我们的内部STR系统进行了比较。
分析了18例儿科患者的50份样本。对于PB、BM和白细胞亚型这两种材料,在所测试的STR系统之间均未观察到显著差异。对内部和商业STR系统共有的每个STR引物进行的嵌合体分析未发现显著差异。
我们的分析表明,即使使用不同的样本来源,两种检测方法也能获得相似的结果。对不同检测系统的进一步评估将有助于提高嵌合体分析的实验室间标准化,以便进行早期临床干预。